Ji G. Su
Beijing, 101111, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines.
Journal: Biochemical and biophysical research communications
Published: May 13, 2026
Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation.
Journal: Science (New York, N.Y.)
Published: September 26, 2024
Prediction of mutation-induced protein stability changes based on the geometric representations learned by a self-supervised method.
Journal: BMC bioinformatics
Published: February 27, 2024
Chimeric virus-like particles of human norovirus constructed by structure-guided epitope grafting elicit cross-reactive immunity against both GI.1 and GII.4 genotypes.
Journal: Journal of virology
Published: October 04, 2023
Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.
Journal: Journal of molecular graphics & modelling
Published: November 28, 2022
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: September 14, 2022
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Journal: eLife
Published: March 14, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Journal: Nature communications
Published: February 17, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: January 12, 2022
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2.
Journal: Cell discovery
Published: October 28, 2021
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
Journal: Journal of molecular graphics & modelling
Published: May 24, 2021
Last Updated: 09/26/2026